Literature DB >> 2536156

Positive genetic selection for gene disruption in mammalian cells by homologous recombination.

J M Sedivy1, P A Sharp.   

Abstract

Efficient modification of genes in mammalian cells by homologous recombination has not been possible because of the high frequency of nonhomologous recombination. An efficient method for targeted gene disruption has been developed. Cells with substitution of exogenous sequences into a chromosomal locus were enriched, by a factor of 100, using a positive genetic selection that specifically selects for homologous recombination at the targeted site. The selection is based on the conditional expression of a dominant selectable marker by virtue of in-frame gene fusion with the target gene. The dominant selectable marker was derived by modification of the Escherichia coli neo gene so that it retains significant activity in mammalian cells after in-frame fusion with heterologous coding sequences. In the example presented here, homologous recombinants were efficiently recovered from a pool in which the targeted gene was disrupted in 1 per 10,000 cells incorporating exogenous DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536156      PMCID: PMC286437          DOI: 10.1073/pnas.86.1.227

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Accurate modification of a chromosomal plasmid by homologous recombination in human cells.

Authors:  K Y Song; F Schwartz; N Maeda; O Smithies; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Modification of DNA ends can decrease end joining relative to homologous recombination in mammalian cells.

Authors:  X B Chang; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  High frequency targeting of genes to specific sites in the mammalian genome.

Authors:  K R Thomas; K R Folger; M R Capecchi
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

4.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

5.  Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene.

Authors:  K R Thomas; M R Capecchi
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

6.  An inducible mammalian amber suppressor: propagation of a poliovirus mutant.

Authors:  J M Sedivy; J P Capone; U L RajBhandary; P A Sharp
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens.

Authors:  P S Jat; C L Cepko; R C Mulligan; P A Sharp
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

8.  Topological requirements for homologous recombination among DNA molecules transfected into mammalian cells.

Authors:  C T Wake; F Vernaleone; J H Wilson
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

9.  Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector.

Authors:  E Robertson; A Bradley; M Kuehn; M Evans
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

10.  Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination.

Authors:  O Smithies; R G Gregg; S S Boggs; M A Koralewski; R S Kucherlapati
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

View more
  34 in total

Review 1.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Increased efficiency of homologous recombination in ES cells by cleavage at both ends of homology in the targeting vector.

Authors:  R Sarig; V Mezger-Lallemand; S Leibovitz; U Nudel
Journal:  Transgenic Res       Date:  2000-04       Impact factor: 2.788

3.  Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks.

Authors:  Matthew H Porteus; Toni Cathomen; Matthew D Weitzman; David Baltimore
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  The frequency of gene targeting in Trypanosoma brucei is independent of target site copy number.

Authors:  Bill Wickstead; Klaus Ersfeld; Keith Gull
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

5.  Activation of cryptic 3' splice sites within introns of cellular genes following gene entrapment.

Authors:  Anna B Osipovich; Erica K White-Grindley; Geoffrey G Hicks; Michael J Roshon; Christian Shaffer; Jason H Moore; H Earl Ruley
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

6.  Stable integrative transformation of Trypanosoma brucei that occurs exclusively by homologous recombination.

Authors:  J Eid; B Sollner-Webb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Two ways to trap a gene in mice.

Authors:  William C Skarnes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

8.  Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs.

Authors:  H te Riele; E R Maandag; A Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  A dominant positive and negative selectable gene for use in mammalian cells.

Authors:  F Schwartz; N Maeda; O Smithies; R Hickey; W Edelmann; A Skoultchi; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

10.  Low level of Hox1.3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption. off.

Authors:  L Jeannotte; J C Ruiz; E J Robertson
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.